4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

16.82 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -100.837-107.494-71.317-56.693-49.306-9.551-11.223
Depreciation & Amortization 5.7493.883.021.4431.0040.6970.626
Deferred Income Tax -0.896000.022.65400
Stock Based Compensation 19.66517.12113.7994.9843.5411.3770.256
Change In Working Capital 0.63-1.336-15.534-0.7110.259-8.77718.539
Accounts Receivables 00.0471.439-0.5080.146-0.803-0.32
Inventory 00-4.536-0.5912.9260.175-0.053
Accounts Payables 0.896-1.6382.2850.0430.5330.438-0.114
Other Working Capital -0.2660.255-14.7220.345-3.346-8.58719.026
Other Non Cash Items -0.1031.1440.8980.0485.1370.0020.039
Operating Cash Flow -75.792-86.685-69.134-50.909-36.711-16.2528.237
Investing Activities:
Investments In Property Plant And Equipment -2.771-11.536-9.11-1-3.203-0.414-0.573
Acquisitions Net 2.77111.5369.110000.024
Purchases Of Investments -54.802-153.313-168.570000
Sales Maturities Of Investments 173.29147.79950008.224
Other Investing Activites -2.771-11.536-9.11-1000.024
Investing Cash Flow 115.717-17.05-172.68-1-3.203-0.4147.675
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 156.8322.73114.296205.6580.0750.1050.016
Common Stock Repurchased 000-278.126-2.2700
Dividends Paid 0000000
Other Financing Activities 27.6240.3553.793351.451-2.2784.4720.016
Financing Cash Flow 156.8323.085118.089278.983-2.19584.5770.016
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 196.757-100.65-123.725227.074-42.10967.91115.928
Cash At End Of Period 249.10852.351153.001276.72649.65291.76123.85